Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.9 Billion USD | -4.62% |
| 2022 | 19.81 Billion USD | -7.21% |
| 2021 | 21.35 Billion USD | -15.93% |
| 2020 | 25.4 Billion USD | 96.0% |
| 2019 | 12.96 Billion USD | 38.16% |
| 2018 | 9.38 Billion USD | -63.85% |
| 2017 | 25.95 Billion USD | 43.26% |
| 2016 | 18.11 Billion USD | 241.0% |
| 2015 | -12.84 Billion USD | -28.34% |
| 2014 | -10.01 Billion USD | -388.63% |
| 2013 | -2.04 Billion USD | -131.91% |
| 2012 | 6.42 Billion USD | 382.03% |
| 2011 | -2.27 Billion USD | -184.81% |
| 2010 | 2.68 Billion USD | 11035.28% |
| 2009 | -24.54 Million USD | 74.76% |
| 2008 | -97.22 Million USD | -128.28% |
| 2007 | 343.8 Million USD | -42.18% |
| 2006 | 594.58 Million USD | 246.07% |
| 2005 | -407.05 Million USD | -45.12% |
| 2004 | -280.49 Million USD | -286.07% |
| 2003 | 150.74 Million USD | 802.31% |
| 2002 | -21.46 Million USD | -123.97% |
| 2001 | 89.54 Million USD | 54.44% |
| 2000 | 57.98 Million USD | 41.41% |
| 1999 | 41 Million USD | 231.83% |
| 1998 | -31.1 Million USD | -7.99% |
| 1997 | -28.8 Million USD | 77.05% |
| 1996 | -125.5 Million USD | -497.62% |
| 1995 | -21 Million USD | -123.4% |
| 1994 | -9.4 Million USD | 0.0% |
| 1992 | -300 Thousand USD | 99.65% |
| 1991 | -86.9 Million USD | -814.74% |
| 1990 | -9.5 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 20.47 Billion USD | 8.33% |
| 2024 Q2 | 20.57 Billion USD | 0.5% |
| 2023 FY | 18.9 Billion USD | -4.62% |
| 2023 Q1 | 21.58 Billion USD | 8.89% |
| 2023 Q3 | 20.2 Billion USD | -3.33% |
| 2023 Q2 | 20.89 Billion USD | -3.17% |
| 2023 Q4 | 18.9 Billion USD | -6.43% |
| 2022 Q1 | 21.91 Billion USD | 2.6% |
| 2022 Q3 | 20.52 Billion USD | -4.44% |
| 2022 FY | 19.81 Billion USD | -7.21% |
| 2022 Q2 | 21.47 Billion USD | -1.99% |
| 2022 Q4 | 19.81 Billion USD | -3.44% |
| 2021 Q1 | 26.1 Billion USD | 2.74% |
| 2021 Q2 | 25.28 Billion USD | -3.14% |
| 2021 Q3 | 23.32 Billion USD | -7.74% |
| 2021 Q4 | 21.35 Billion USD | -8.43% |
| 2021 FY | 21.35 Billion USD | -15.93% |
| 2020 Q3 | 16.4 Billion USD | -5.49% |
| 2020 Q2 | 17.35 Billion USD | 23.57% |
| 2020 FY | 25.4 Billion USD | 96.0% |
| 2020 Q1 | 14.04 Billion USD | 8.36% |
| 2020 Q4 | 25.4 Billion USD | 54.87% |
| 2019 Q1 | 9.65 Billion USD | 2.87% |
| 2019 Q3 | 15.11 Billion USD | 1.83% |
| 2019 Q2 | 14.84 Billion USD | 53.8% |
| 2019 FY | 12.96 Billion USD | 38.16% |
| 2019 Q4 | 12.96 Billion USD | -14.24% |
| 2018 Q3 | 12.74 Billion USD | -19.45% |
| 2018 Q2 | 15.82 Billion USD | -26.08% |
| 2018 Q4 | 9.38 Billion USD | -26.4% |
| 2018 Q1 | 21.41 Billion USD | -17.5% |
| 2018 FY | 9.38 Billion USD | -63.85% |
| 2017 FY | 25.95 Billion USD | 43.26% |
| 2017 Q4 | 25.95 Billion USD | 46.19% |
| 2017 Q3 | 17.75 Billion USD | 0.97% |
| 2017 Q2 | 17.58 Billion USD | 9.65% |
| 2017 Q1 | 16.03 Billion USD | -11.49% |
| 2016 Q3 | 17.26 Billion USD | 10.36% |
| 2016 Q1 | 16.5 Billion USD | 228.47% |
| 2016 Q2 | 15.64 Billion USD | -5.24% |
| 2016 Q4 | 18.11 Billion USD | 4.95% |
| 2016 FY | 18.11 Billion USD | 241.0% |
| 2015 Q2 | -7.41 Billion USD | 30.25% |
| 2015 Q4 | -12.84 Billion USD | 7.97% |
| 2015 FY | -12.84 Billion USD | -28.34% |
| 2015 Q3 | -13.96 Billion USD | -88.41% |
| 2015 Q1 | -10.62 Billion USD | -6.11% |
| 2014 Q4 | -10.01 Billion USD | -61.96% |
| 2014 Q3 | -6.18 Billion USD | 28.9% |
| 2014 Q2 | -8.69 Billion USD | -36.74% |
| 2014 FY | -10.01 Billion USD | -388.63% |
| 2014 Q1 | -6.35 Billion USD | -210.32% |
| 2013 Q4 | -2.04 Billion USD | -138.64% |
| 2013 Q3 | 5.3 Billion USD | 3.25% |
| 2013 FY | -2.04 Billion USD | -131.91% |
| 2013 Q1 | 6.13 Billion USD | -4.47% |
| 2013 Q2 | 5.13 Billion USD | -16.27% |
| 2012 Q2 | 7.47 Billion USD | -6.31% |
| 2012 FY | 6.42 Billion USD | 382.03% |
| 2012 Q4 | 6.42 Billion USD | -11.08% |
| 2012 Q3 | 7.22 Billion USD | -3.39% |
| 2012 Q1 | 7.97 Billion USD | 450.41% |
| 2011 FY | -2.27 Billion USD | -184.81% |
| 2011 Q4 | -2.27 Billion USD | -176.29% |
| 2011 Q3 | 2.98 Billion USD | 0.39% |
| 2011 Q2 | 2.97 Billion USD | 11.44% |
| 2011 Q1 | 2.66 Billion USD | -0.63% |
| 2010 Q4 | 2.68 Billion USD | 10.54% |
| 2010 Q1 | 307.1 Million USD | 1351.19% |
| 2010 FY | 2.68 Billion USD | 11035.28% |
| 2010 Q2 | 270 Million USD | -12.08% |
| 2010 Q3 | 2.42 Billion USD | 799.3% |
| 2009 Q3 | 389.65 Million USD | -29.98% |
| 2009 Q1 | -489.57 Million USD | -403.53% |
| 2009 Q4 | -24.54 Million USD | -106.3% |
| 2009 FY | -24.54 Million USD | 74.76% |
| 2009 Q2 | 556.48 Million USD | 213.67% |
| 2008 Q2 | 210.51 Million USD | -64.17% |
| 2008 Q1 | 587.61 Million USD | 70.92% |
| 2008 Q4 | -97.22 Million USD | -182.5% |
| 2008 Q3 | 117.85 Million USD | -44.02% |
| 2008 FY | -97.22 Million USD | -128.28% |
| 2007 FY | 343.8 Million USD | -42.18% |
| 2007 Q3 | 835.21 Million USD | 18.3% |
| 2007 Q1 | 667.13 Million USD | 12.2% |
| 2007 Q2 | 705.99 Million USD | 5.83% |
| 2007 Q4 | 343.8 Million USD | -58.84% |
| 2006 Q3 | 880.95 Million USD | 43.19% |
| 2006 Q2 | 615.21 Million USD | 2671.87% |
| 2006 Q4 | 594.58 Million USD | -32.51% |
| 2006 Q1 | -23.92 Million USD | 94.12% |
| 2006 FY | 594.58 Million USD | 246.07% |
| 2005 FY | -407.05 Million USD | -45.12% |
| 2005 Q4 | -407.05 Million USD | 31.28% |
| 2005 Q3 | -592.31 Million USD | 25.32% |
| 2005 Q2 | -793.18 Million USD | -181.75% |
| 2005 Q1 | -281.52 Million USD | -0.37% |
| 2004 Q3 | 43.84 Million USD | -63.08% |
| 2004 Q2 | 118.74 Million USD | -37.42% |
| 2004 Q1 | 189.74 Million USD | 25.87% |
| 2004 FY | -280.49 Million USD | -286.07% |
| 2004 Q4 | -280.49 Million USD | -739.77% |
| 2003 FY | 150.74 Million USD | 802.31% |
| 2003 Q4 | 150.74 Million USD | -69.37% |
| 2003 Q3 | 492.15 Million USD | 15.51% |
| 2003 Q2 | 426.06 Million USD | -10.8% |
| 2003 Q1 | 477.67 Million USD | 2325.46% |
| 2002 Q1 | 136.34 Million USD | 52.27% |
| 2002 Q4 | -21.46 Million USD | -116.68% |
| 2002 Q3 | 128.65 Million USD | -0.25% |
| 2002 Q2 | 128.97 Million USD | -5.4% |
| 2002 FY | -21.46 Million USD | -123.97% |
| 2001 Q3 | 215.87 Million USD | 4.24% |
| 2001 Q1 | 177.39 Million USD | 205.95% |
| 2001 FY | 89.54 Million USD | 54.44% |
| 2001 Q4 | 89.54 Million USD | -58.52% |
| 2001 Q2 | 207.09 Million USD | 16.75% |
| 2000 Q4 | 57.98 Million USD | 255.18% |
| 2000 Q2 | 43.52 Million USD | -12.49% |
| 2000 Q1 | 49.73 Million USD | 21.31% |
| 2000 FY | 57.98 Million USD | 41.41% |
| 2000 Q3 | -37.36 Million USD | -185.84% |
| 1999 Q3 | 25.4 Million USD | 157.34% |
| 1999 Q2 | -44.3 Million USD | 22.55% |
| 1999 Q4 | 41 Million USD | 61.42% |
| 1999 Q1 | -57.2 Million USD | -83.92% |
| 1999 FY | 41 Million USD | 231.83% |
| 1998 Q3 | -41.7 Million USD | -18.47% |
| 1998 Q2 | -35.2 Million USD | -10.69% |
| 1998 FY | -31.1 Million USD | -7.99% |
| 1998 Q4 | -31.1 Million USD | 25.42% |
| 1998 Q1 | -31.8 Million USD | -10.42% |
| 1997 Q2 | -134.1 Million USD | -35.45% |
| 1997 Q1 | -99 Million USD | 21.12% |
| 1997 FY | -28.8 Million USD | 77.05% |
| 1997 Q3 | -41.7 Million USD | 68.9% |
| 1997 Q4 | -28.8 Million USD | 30.94% |
| 1996 Q3 | -151.6 Million USD | 14.78% |
| 1996 Q4 | -125.5 Million USD | 17.22% |
| 1996 Q2 | -177.9 Million USD | -307.09% |
| 1996 Q1 | -43.7 Million USD | 0.0% |
| 1996 FY | -125.5 Million USD | -497.62% |
| 1995 Q3 | -65.3 Million USD | -9228.57% |
| 1995 Q1 | -22 Million USD | -260.66% |
| 1995 Q2 | -700 Thousand USD | 96.82% |
| 1995 FY | -21 Million USD | -123.4% |
| 1994 Q1 | -9.4 Million USD | -91.84% |
| 1994 FY | -9.4 Million USD | 0.0% |
| 1994 Q4 | -6.1 Million USD | 64.53% |
| 1994 Q3 | -17.2 Million USD | 49.41% |
| 1994 Q2 | -34 Million USD | -261.7% |
| 1993 Q1 | -300 Thousand USD | 99.35% |
| 1993 Q2 | -1.4 Million USD | -366.67% |
| 1993 Q3 | 800 Thousand USD | 157.14% |
| 1993 Q4 | -4.9 Million USD | -712.5% |
| 1992 Q1 | -86.9 Million USD | 0.0% |
| 1992 Q3 | -800 Thousand USD | 95.24% |
| 1992 FY | -300 Thousand USD | 99.65% |
| 1992 Q4 | -46.2 Million USD | -5675.0% |
| 1992 Q2 | -16.8 Million USD | 80.67% |
| 1991 Q1 | -9.5 Million USD | 0.0% |
| 1991 FY | -86.9 Million USD | -814.74% |
| 1990 FY | -9.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amgen Inc. | 53.66 Billion USD | 64.78% |
| AstraZeneca PLC | 22.78 Billion USD | 17.031% |
| Biogen Inc. | 6.28 Billion USD | -200.59% |
| MIRA Pharmaceuticals, Inc. | -4.59 Million USD | 411236.04% |
| Scilex Holding Company | 124.54 Million USD | -15077.209% |
| Scilex Holding Company | 124.54 Million USD | -15077.209% |